New System Protects Healthcare Workers from Hazardous Drug Exposure
By HospiMedica International staff writers Posted on 11 Aug 2015 |
Image: The Halo Closed System Transfer Device (CSTD) (Photo courtesy of Corvida Medical).
A novel concept in hazardous drug protection provides health care professionals with a simple design that ensures compatibility with existing work procedures.
The Halo Closed System Transfer Device (CSTD) is an airtight, leak-proof, closed system that provides complete fluid and vapor containment and a strong vial attachment. Tests have shown the system prevents escape of hazardous drug or vapor concentration, bars the transfer of environmental contaminants, and prevents microbial ingress. The easy to use system comes with few pieces and fewer steps, and is compatible with existing work procedures, protocols, and disposable equipment.
The system mechanically prohibits the transfer of environmental contaminants into the system, and the escape of drug or vapor concentrations outside the system. This is achieved by addressing safety concerns for each connection type, such as drug vial adapters, syringe and line adapters, and bag spikes, containing the drug through each of the reconstitution and transfer steps. The Halo CSTD is a product of Corvida Medical (Coralville, IA, USA), and has been approved by the US Food and Drug Administration (FDA).
“We are focused on developing and introducing products designed to meet critical unmet needs, and have worked closely with thought leaders throughout our product development efforts. The feedback on Halo has been phenomenal,” said Kent Smith, President and CEO of Corvida Medical. “Health care professionals appreciate Halo’s simplicity and we look forward to introducing it to the market.”
Healthcare workers are continuously exposed to hazardous drugs during the preparation and delivery of chemotherapy, which can cause serious health problems, including cancer, infertility, genetic mutations, and other adverse effects. Protective equipment intended to shield from these dangers often can be complicated, difficult to use, and provide incomplete solutions.
Related Links:
Corvida Medical
The Halo Closed System Transfer Device (CSTD) is an airtight, leak-proof, closed system that provides complete fluid and vapor containment and a strong vial attachment. Tests have shown the system prevents escape of hazardous drug or vapor concentration, bars the transfer of environmental contaminants, and prevents microbial ingress. The easy to use system comes with few pieces and fewer steps, and is compatible with existing work procedures, protocols, and disposable equipment.
The system mechanically prohibits the transfer of environmental contaminants into the system, and the escape of drug or vapor concentrations outside the system. This is achieved by addressing safety concerns for each connection type, such as drug vial adapters, syringe and line adapters, and bag spikes, containing the drug through each of the reconstitution and transfer steps. The Halo CSTD is a product of Corvida Medical (Coralville, IA, USA), and has been approved by the US Food and Drug Administration (FDA).
“We are focused on developing and introducing products designed to meet critical unmet needs, and have worked closely with thought leaders throughout our product development efforts. The feedback on Halo has been phenomenal,” said Kent Smith, President and CEO of Corvida Medical. “Health care professionals appreciate Halo’s simplicity and we look forward to introducing it to the market.”
Healthcare workers are continuously exposed to hazardous drugs during the preparation and delivery of chemotherapy, which can cause serious health problems, including cancer, infertility, genetic mutations, and other adverse effects. Protective equipment intended to shield from these dangers often can be complicated, difficult to use, and provide incomplete solutions.
Related Links:
Corvida Medical
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration